Prognosis of critically ill patients
Conditions
Interventions
Experience group:Shenlingbaizhu powder
control group:placebo
Sponsors
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Signed informed consent; ICU patients; aged 18-85 years; APACHE score than less than or equal to 25 but more than 15 points; to enteral nutrition and enteral nutrition time more than 72 hours of ICU patients.
Exclusion criteria
Exclusion criteria: Give up the treatment of drugs used in the scheme; allergy; been currently participating in the studies of other drugs; APACHE II score 25 points; there are contraindications to enteral nutrition; there is partial or complete intestinal obstruction, intestinal ischemia or infarction there; gastrointestinal syndrome or short bowel syndrome (small intestine length less than 22cm); the doctors prescribed, at the beginning of the study SHENLINGBAISHU treatment within 2 weeks before receiving the expected death within 48 hours; patients; at the same time to participate in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Length of stay;Ventilator use time;Routine blood test;liver function; | — |
Countries
China
Contacts
Public ContactPeiyang Gao
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Outcome results
None listed